title: Metabolites of ginger component [6]-shogaol remain bioactive in cancer cells and have low toxicity in normal cells: chemical synthesis and biological evaluation.
abstract: Our previous study found that [6]-shogaol, a major bioactive component in ginger, is extensively metabolized in cancer cells and in mice. It is unclear whether these metabolites retain bioactivity. The aim of the current study is to synthesize the major metabolites of [6]-shogaol and evaluate their inhibition of growth and induction of apoptosis in human cancer cells. Twelve metabolites of [6]-shogaol (M1, M2, and M4-M13) were successfully synthesized using simple and easily accessible chemical methods. Growth inhibition assays showed that most metabolites of [6]-shogaol had measurable activities against human cancer cells HCT-116 and H-1299. In particular, metabolite M2 greatly retained the biological activities of [6]-shogaol, with an IC(50) of 24.43 µM in HCT-116 human colon cancer cells and an IC(50) of 25.82 µM in H-1299 human lung cancer cells. Also exhibiting a relatively high potency was thiol-conjugate M13, with IC(50) values of 45.47 and 47.77 µM toward HCT-116 and H-1299 cells, respectively. The toxicity evaluation of the synthetic metabolites (M1, M2, and M4-M13) against human normal fibroblast colon cells CCD-18Co and human normal lung cells IMR-90 demonstrated a detoxifying metabolic biotransformation of [6]-shogaol. The most active metabolite M2 had almost no toxicity to CCD-18Co and IMR-90 normal cells with IC(50)s of 99.18 and 98.30 µM, respectively. TUNEL (Terminal deoxynucleotidyl transferase dUTP nick end labeling) assay indicated that apoptosis was triggered by metabolites M2, M13, and its two diastereomers M13-1 and M13-2. There was no significant difference between the apoptotic effect of [6]-shogaol and the effect of M2 and M13 after 6 hour treatment.
authors: Center for Excellence in Post-Harvest Technologies, North Carolina Agricultural and Technical State University, North Carolina Research Campus, Kannapolis, North Carolina, USA.
authors: Yingdong
authors: Y
authors: Zhu
authors: Renaud F
authors: RF
authors: Warin
authors: Dominique N
authors: DN
authors: Soroka
authors: Huadong
authors: H
authors: Chen
authors: Shengmin
authors: S
authors: Sang
mesh_terms: D000970:Antineoplastic Agents / Q000737:chemistry / Q000494:pharmacology* / Q000633:toxicity; D017209:Apoptosis / Q000187:drug effects; D002396:Catechols / Q000737:chemistry / Q000494:pharmacology* / Q000633:toxicity; D002460:Cell Line; D020939:Zingiber officinale / Q000737:chemistry*; D045325:HCT116 Cells; D006801:Humans
chemical_list: D000970:Antineoplastic Agents; D002396:Catechols; C040115:shogaol
references: Crit Rev Food Sci Nutr. 2012;52(8):651-88
references: 22591340
references: J Agric Food Chem. 2009 Nov 25;57(22):10645-50
references: 19877681
references: Br J Nutr. 2001 Aug;86 Suppl 1:S37-53
references: 11520423
references: J Altern Complement Med. 2012 May;18(5):440-4
references: 22540971
references: Cancer Treat Rev. 2009 Nov;35(7):597-607
references: 19660870
references: J Immunol Methods. 1983 Dec 16;65(1-2):55-63
references: 6606682
references: Nat Rev Cancer. 2003 Oct;3(10):768-80
references: 14570043
references: Crit Rev Food Sci Nutr. 2004;44(6):453-64
references: 15615428
references: Drug Metab Dispos. 2012 Apr;40(4):742-53
references: 22246389
references: Crit Rev Food Sci Nutr. 2011 Jul;51(6):499-523
references: 21929329
references: Proc Nutr Soc. 2008 Aug;67(3):253-6
references: 18452640
references: Eur J Cancer. 2005 Sep;41(13):1889-910
references: 16005206
references: PLoS One. 2012;7(6):e39664
references: 22768104
references: Br J Cancer. 2011 Jan 4;104(1):6-11
references: 21119663
references: Mol Nutr Food Res. 2010 Sep;54(9):1296-306
references: 20336681
references: Org Lett. 2005 Sep 1;7(18):3929-32
references: 16119934
references: Arch Pharm Res. 2008 Apr;31(4):415-8
references: 18449496
references: J Cell Biochem. 2008 May 1;104(1):339-56
references: 18092339